Non-interventional
Non-interventional is an intervention with 135 clinical trials. Currently 17 active trials ongoing. Historical success rate of 95.6%.
Success Metrics
Based on 86 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
87.8%
86 of 98 finished
12.2%
12 ended early
17
trials recruiting
135
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiency
A Study to Assess the Safety and Risk of Hypersensitivity Reactions of Sulbactam-durlobactam in Adults With Acinetobacter Baumannii-calcoaceticus (ABC) Complex Infection
A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants
Rutgers COVID-19 Cohort Study
An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant
Clinical Trials (135)
Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiency
A Study to Assess the Safety and Risk of Hypersensitivity Reactions of Sulbactam-durlobactam in Adults With Acinetobacter Baumannii-calcoaceticus (ABC) Complex Infection
A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants
Rutgers COVID-19 Cohort Study
An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant
Extension Study to Evaluate the Long-Term Outcomes of Pediatric Patients Who Received Treatment for Retinopathy of Prematurity in the VGFTe-ROP-1920 Study (Acronym: Butterfleye Next)
Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
A Trial That Evaluates Disease Characteristics in Hemophilia B Adult Male Participants Receiving Prophylaxis With Standard of Care Factor IX Protein (FIX) Replacement Therapy
Interview of Patients With HR+/HER2- Metastatic Breast Cancer Who Received Capivasertib + Fulvestrant
Province of Ontario Strategy for Personalized Management of Pancreatic Cancer Trial
The Role of Ectopic Fat and Heart Attack Risk in HIV
Understanding and Enhancing Health-Related Social Needs (HRSN) Screening Among Community Oncology Practices
A Safety and Efficacy Long-Term Follow-up Study of Adult Participants Treated With Gene Modified T Cells
Role of IL-5R Signaling in Non-eosinophil Upper Airway Cells in CRSwNP
The Natural History of Recovery After Stroke
Treating Caregiver Depression to Improve Childhood Asthma: Impact and Mediators
A Trial Monitoring Therapy Pathways of Asthma Patients Treated With an Extrafine ICS/LABA/LAMA Single-inhaler Triple Therapy in a Real-world Setting and Characterizing the Effects on Health-related Out-comes
TRAQinform Assessment of Immunotherapy Response
The Effect of GLP-1 Analogues on Liver Steatosis and Fibrosis in Diabetic and Obese Patients in a Clinical Setting
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 135